PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers

Preimplantation Genetic Diagnosis (PGD) is a method of testing in vitro embryos as an alternative to prenatal diagnosis with possible termination of pregnancy in case of an affected child. Recently, PGD for hereditary breast and ovarian cancer caused by BRCA1 and BRCA2 mutations has found its way in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Drüsedau, Marion, Dreesen, Jos C, Derks-Smeets, Inge, Coonen, Edith, van Golde, Ron, van Echten-Arends, Jannie, Kastrop, Peter M M, Blok, Marinus J, Gómez-García, Encarna, Geraedts, Joep P, Smeets, Hubert J, de Die-Smulders, Christine E, Paulussen, Aimée D
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3831069/
https://ncbi.nlm.nih.gov/pubmed/23531862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.50
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items